The present invention relates to compounds of the general Formula (I),
wherein R
1
, R
2
and R
3
are as defined in the description; to pharmaceutical compositions comprising these compounds; and to the use of the compounds for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, and/or CNS disorders.